5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects

Psychopharmacology

Volumn 127, Issue 1, 1996, Pages 108-112

  Coccaro, Emil F ^a   Kavoussi, Richard J ^a   Cooper, Thomas B ^b   Hauger, Richard ^c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5 HT3; d Fenfluramine; Ondansetron; Prolactin

Indexed keywords

DEXFENFLURAMINE; NORFENFLURAMINE; ONDANSETRON; PLACEBO; PROLACTIN; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN AGONIST; FENFLURAMINE; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG METABOLISM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; VOLUNTEER; BLOOD; SECRETION;

ADULT; FENFLURAMINE; HUMANS; MALE; ONDANSETRON; PROLACTIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0029658395     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02805982     Document Type: Article

References (31)

1. Anderson IM, Cowen PJ, Grahame-Smith DC, (1988) The effect of BRL 43694 on the neuroendocrine responses to l-tryptophan infusion. J Psychopharmacol 2:2
2. Andrews PLR, Rappaport WG, Sanger GJ (1988) Neuropharmacology of emesis induced by anticancer therapy. Trends Pharmacol Sci 9:334-341
3. Broocks A, Pigott T, Canter S, Hills J, Murphy DI. (1992) Acute administration of ondansetron and m-CPP in healthy volunteers: behavioral and biological results. Clin Neuropharmacol 15[SI]:591
4. Coccaro EF, Kavoussi RJ (1994) The neuropsychopharmacologic challenge in biological psychiatry. Clin Chem 40:319-327
5. Coccaro HF, Kavoussi RJ, Hauger RL (1995) Receptor subtyping of the prolactin response to d-fenfluramine challenge in healthy volunteers. Abstracts of the 34th Annual Meeting of the American College of Neuropsychopharmacology, p 126
6. Coccaro EF, Kavoussi RJ, Oakes M, Hauger RL (1996) Amesergide completely blocks the prolactin response to d-fenfluramine in healthy male subjects. Psychopharmacology (in press)
7. Di Renzo G, Amoroso S, Taglialatela M, Canzoniero L, Basile V, Fatatis A (1989) Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion. Eur J Pharmacol 162:371-373
8. Garattini S, Mennini T, Samanin R (1987) From fenfluramine race-mate to d-fenfluramine: specificity and potency of the effects on the serotonergic system and food intake. Ann NY Acad Sci 499:156-165
9. 3 receptor blockade on the psychobiological response to clomipramine challenge. Neuropsychopharmacology 10:269S
10. Goodall EM, Cowan PJ, Franklin M, Silverstone T (1993) Ritanserin attenuates anorectic, endocrine and thermal responses to d-fenfluramine in human volunteers. Psychopharmacology 112:461-466
11. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994) VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:158-203
12. 3 receptor blockade: a preliminary study in healthy male volunteers. Psychopharmacology 112:142-144
13. 3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan. Neuroendocrinology 55:336-343
14. Klein DN, Ouimette PC, L|Kelly HS, Ferro T, Riso LP (1994) Test-retest reliability of a team consensus best-estimate diagnoses of axis I and II disorders in a family study. Am J Psychiatry 151:1043-1047
15. Krebs HA, Chens LK, Wright GJ (1984) Determination of fenfluramine and norfenfluramine in plasma using a nitrogen-sensitive detector. J Chromatogr 310:412-417
16. Kuhn CM, Vogel RA, Mailman RB, Mueller RA, Schanberg SM, Bresse GR (1981) Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats. Psychopharmacology 73: 188-193
17. Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM (1982) Best estimate of lifetime psychiatric diagnosis: a methodologic study. Arch Gen Psychiatry 39:879-883
18. 3 receptors in the secretion of prolactin, ACTH and renin. Neuroendocrinology 58:65-70
19. Lewis DA, Sherman BM (1985) Serotonergic regulation of prolactin and growth hormone secretion in man. Acta Endocrinol 110:152-157
20. Meltzer HY, Maes M (1994) Effect of pindolol on the 1-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man. Psychopharmacology 114:635-643
21. Olivier B, Tulp MThM, Mos J (1991) Serotonergic receptors in anxiety and aggression; evidence from animal pharmacology. Hum Psychopharmacol 6:S73-S78
22. Palazidou E, Stephenson, Butler J, Coskeran P, Chambers S, McGregor AM (1995) Evidence for 5-hydroxytryptamine-1a receptor involvement in the control of prolactin secretion in man. Psychopharmacology 119:311-314
23. Park SBG, Cowen PJ (1995) Effect of pindolol on the prolactin response to d-fenfluramine. Psychopharmacology 118:471-474
24. Pfohl B, Zimmerman M (1989) Structured interview for the diagnosis of DSM-III-R personality disorders. University of Iowa College of Medicine, Iowa
25. Physician's Desk Reference (1995) Zofran tablets (ondansetron). Medical Economics Data Production Company, Montvale, N.J., pp 861-862
26. Quattrone A, DiRenzo G, Schellini G, Tedeschi G, Preziosi P (1979) Effect of midbrain raphe lesion or 5,7-dihydroxytryptamine treatment on the prolactin-releasing action of quipazine and d-fenfluramine in rats. Brain Res 174:71-79
27. Quattrone A, Tedeschi G, Agugla F, Scopacaso F, DiRenzo GF, Annuziato L (1983) Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine. Br J Clin Pharmacol 16:471-475
28. Simpson KH, Murphy P, Colthup PV, Whelan P (1992) Concentration of ondansetron in cerebrospinal fluid following oral dosing in volunteers. Psychopharmacology 109:497-498
29. Spitzer RL (1987) The diagnostic and statistical manual third edition revised (DSM-III-R). American Psychiatric Press, Washington, DC
30. Spitzer RL, Endicott J (1978) Schedule for affective disorders and schizophrenia. NY State Psychiatric Institute, New York
31. 1 serotonin receptors in the medial basal hypothalamus stimulates prolactin secretion in the unanesthetized rat. Neuroendocrinology 47:83-87